Demographic, screening (for headache) and headache-diagnostic questions (based on ICHD-II [17]) were supplemented by several question sets addressing impact.
Demographic, screening (for headache) and headache-diagnostic questions (the last based on the international classification of headache disorders, 2nd edition (ICHD-II) [7]) were supplemented by several question sets addressing impact, together totalling 103 items.
Those declining study entry or ineligible were asked to complete a brief demographic screening tool.
Demographic, screening history, risk factors, seropositivity, accuracy and concordance results are reported in tables 2 and 3.
Full pathological, demographic, screening and 5-year survival data were either available from the Scottish Cancer Registry or obtained from the patient's case record or pathology records.
Practice demographics, screening patterns, and the numeric risks quoted in counseling were analyzed.
The control and the intervention groups had overlapping 95% confidence intervals (CI) for demographics, screening tests results, and cases with planned treatment for latent TB (Table 1).
Characteristics of the two samples, i.e. socio demographics, screening experience, perceived risk and family history of CRC, and health status were described using percentages for categorical variables and the mean (sd) for continuous variables.
It has a modular design: separate question sets cover demographic characteristics, screen for caseness (headache disorder present or not), diagnose headache type and address each of the several quantifiable components of burden.
The NCSP database includes information on participants' demographic characteristics, screening date, and screening results.
